Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romiplostim N01 + ATRA vs Romiplostim N01 for PICIT in GI Solid Tumors
NCT07586813Phase 2Recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Dec 2025
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tretinoin in chemotherapy-induced thrombocytopenia (CIT), sponsored by Peking University People's Hospital. Started Dec 2025; status: recruiting.
02
Drugs
tretinoin
03
Conditions
chemotherapy-induced thrombocytopenia (CIT)
Beyond the preview
Go deeper on NCT07586813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07586813.